C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2004
12/29/2004	WO2004113517A2 IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA
12/29/2004	WO2004113513A2 Methods and compositions for modulating stem cell growth and differentiation
12/29/2004	WO2004113511A2 Cell line and uses thereof
12/29/2004	WO2004113503A2 Mbms as modifiers of branching morphogenesis and methods of use
12/29/2004	WO2004113501A2 Methods and compositions relating to lipid accumulation
12/29/2004	WO2004113500A2 B7s1: an immune modulator
12/29/2004	WO2004113499A2 Modulation of flowering time by the pft1 locus
12/29/2004	WO2004113497A2 Gene delivery to tumors
12/29/2004	WO2004113386A2 Modified hirudin proteins and t-cell epitopes in hirudin
12/29/2004	WO2004113384A1 Use of a vegf receptor gene or gene product
12/29/2004	WO2004113383A2 Pegylated soluble gp130-dimers useful as a medicament
12/29/2004	WO2004113382A1 Recombinant igf expression systems
12/29/2004	WO2004113381A1 Relaxin superfamily peptide analogues
12/29/2004	WO2004113380A1 Use of cardiotrophin to modulate stem cell proliferation
12/29/2004	WO2004113379A1 Interferon gamma-like protein
12/29/2004	WO2004113378A2 Control of lactation and peptides therefore
12/29/2004	WO2004113377A1 Purification of her-2 variants
12/29/2004	WO2004113376A1 Modified oleosins
12/29/2004	WO2004113374A2 Chlamydia pneumoniae antigens
12/29/2004	WO2004113373A1 Overexpression of the cyddc transporter
12/29/2004	WO2004113371A2 Virulence-associated adhesins
12/29/2004	WO2004113370A1 Novel surface protein (hbsag) variant of hepatitis b virus
12/29/2004	WO2004113369A1 Novel surface protein (hbsag) variant of hepatitis b virus
12/29/2004	WO2004113367A1 Peptide having apoptosis-inhibiting activity
12/29/2004	WO2004113361A2 Novel prokineticin receptor isoforms and methods of use
12/29/2004	WO2004112832A2 Immunogenic compositions comprising multiple gonococcal antigens
12/29/2004	WO2004112831A2 High titer recombinant influenza viruses for vaccines and gene therapy
12/29/2004	WO2004112820A2 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity
12/29/2004	WO2004112728A2 Methods and agents for treating axonal damage, inhibition of neurotransmitter release and pain transmission, and blocking calcium influx in neurons
12/29/2004	WO2004112727A2 Aav virions with decreased immunoreactivity and uses therefor
12/29/2004	WO2004112706A2 Vaccines, immunotherapeutics and methods for using the same
12/29/2004	WO2004112703A2 Interleukin-21 analogs
12/29/2004	WO2004112691A2 Interferon gamma therapies for idiopathic pulmonary fibrosis
12/29/2004	WO2004112572A2 Monitoring immunologic, hematologic and inflammatory diseases
12/29/2004	WO2004112570A2 Detection of survivin in the biological fluids of cancer patients
12/29/2004	WO2004112565A2 Diagnosis and treatment of liver, pulmonary and cardiac fibrosis
12/29/2004	WO2004112473A1 Novel animal model for epilepsy
12/29/2004	WO2004112468A1 Plant limit dextrinase inhibitor
12/29/2004	WO2004101798A3 Method for the preparation of transgenic plants characterised by geminivirus lasting resistance
12/29/2004	WO2004101608A3 Apo2l (trail) receptor binding peptides and uses thereof
12/29/2004	WO2004099418A8 Fused protein
12/29/2004	WO2004099244A3 Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation
12/29/2004	WO2004096124A3 Compositions and methods for the diagnosis and treatment of tumor
12/29/2004	WO2004093790A3 Yeast ectopically expressing abnormally processed proteins and uses therefor
12/29/2004	WO2004084942A3 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18)
12/29/2004	WO2004082640A3 Human serum albumin conjugates with therapeutic compounds
12/29/2004	WO2004081045A3 Vaccine related to modified apolipoprotein c-iii
12/29/2004	WO2004081043A3 Baff mutants with at least one amino acid substitution and methods of their production
12/29/2004	WO2004078926A3 Immunologigal markers
12/29/2004	WO2004078097A3 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer
12/29/2004	WO2004074458A3 N-acetylglucosaminyltransferase iii expression in lower eukaryotes
12/29/2004	WO2004065556A3 Pet family of efflux proteins
12/29/2004	WO2004065538A3 Protein domain related to deafness, osteoarthritis and abnormal cell proliferation
12/29/2004	WO2004053100A3 Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same
12/29/2004	WO2004053061A3 Methods of therapy and diagnosis using targeting of cells that express lax
12/29/2004	WO2004052914A3 Compositions and methods for inhibiting malaria protease falcipain-2
12/29/2004	WO2004048599A3 Transporters and ion channels
12/29/2004	WO2004046332A3 Amplified genes involved in cancer
12/29/2004	WO2004046177A3 Unexpected surface proteins in neisseria meningitidis
12/29/2004	WO2004043886A3 Production of pharmaceutically active proteins in sprouted seedlings
12/29/2004	WO2004042004A3 Mouse model for autoimmune disorders
12/29/2004	WO2004039324A3 Anti-hiv (sl9) compounds
12/29/2004	WO2004039309A3 Dc-sign isoforms, related compositions and methods for their use in disease therapy
12/29/2004	WO2004035741A3 Susceptibility gene for myocardial infarction; methods of treatment
12/29/2004	WO2004033664A3 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
12/29/2004	WO2004007682A3 Methods and compositions for modulating t helper (th) cell development and function
12/29/2004	WO2004005481A3 Methods for identifying modulators of mda-7 mediated apoptosis
12/29/2004	WO2003104429A3 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics
12/29/2004	WO2003104270A3 Dudulin genes, non-human animal model: uses in human hematological disease
12/29/2004	WO2003099847A3 Method for enzymatic production of glp-1 (7-36) amide peptides
12/29/2004	WO2003097802A3 Cancer-linked gene as target for chemotherapy
12/29/2004	WO2003087128A3 Secretory signal sequences and uses thereof
12/29/2004	WO2003086453A8 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
12/29/2004	WO2003057178A3 Viral capsid assembly intermediates
12/29/2004	WO2003057146A3 Novel compositions and methods for cancer
12/29/2004	WO2003045984A3 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
12/29/2004	WO2003008621A3 87144, human amino acid transporter family member and uses therefor
12/29/2004	WO2002089747A3 Compositions and methods for the therapy and diagnosis of prostate cancer
12/29/2004	WO2000061774A3 Bone morphogenic proteins
12/29/2004	EP1491890A1 Method of evaluating hair growth-promoting activity
12/29/2004	EP1491889A2 Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-beta peptide (x = 41) and tau
12/29/2004	EP1491631A1 Method of screening transporter inhibitor
12/29/2004	EP1491556A1 Humanized immunoglobulins and their production and use
12/29/2004	EP1491554A1 PEGylated soluble gp130-dimers useful as a medicament
12/29/2004	EP1491553A1 Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumours
12/29/2004	EP1491550A1 31 human secreted proteins
12/29/2004	EP1491216A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
12/29/2004	EP1491215A1 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like
12/29/2004	EP1491210A1 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles
12/29/2004	EP1491207A1 Novel screening method
12/29/2004	EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/29/2004	EP1490690A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
12/29/2004	EP1490689A1 Novel compositions and methods in cancer associated with altered expression of prlr
12/29/2004	EP1490688A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
12/29/2004	EP1490686A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
12/29/2004	EP1490683A2 Treatment of congestive heart failure with natriuretic peptide and a diuretic
12/29/2004	EP1490681A2 Peptide screen
12/29/2004	EP1490680A2 Identifying peptide modifications
12/29/2004	EP1490509A2 Modulating insulin receptor signaling
12/29/2004	EP1490500A1 Novel compositions and methods in cancer associated with altered expression of tbx21

1 ... 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 ... 2916